New podcast episode drop!
@RhinoScience from @humblebeebio on their biopolymer's unusual properties, plant vs microbial biofactories, and using rapid and distributed R&D.
https://t.co/WduEyBhSdz
@michael_gilman It was a governance failure and investor DD failure. But primarily it was a really twisted fraud. With Theranos, patient's were the ones most affected by this fraud
@SaraNayeem Thanks @SaraNayeem for the advice about this tricky issue. Valuations at early stage cab vary wildly (in my limited experience). Everyone has their opinion & method. Is the the valuation ultimately set by the market, by the different term sheets received?
Thanks to the @cleantechgroup for including @humblebeebio on your 50 to watch list. The world of CleanTech is exciting, and it will be great to contribute our technology to this future.
#CleantechGroup is excited to launch the 4th annual edition of #Cleantech50toWatch! Download the Cleantech 50 to Watch and get to know these early-stage innovators acting on the climate crisis and find ways to support the innovative work that they do: https://t.co/dyTcTNCrWy
@LifeSciVC Triple 'Like' this analysis. Pricing needs to match the health outcomes. Cost aside, so pleased for the ALS community that there's another treatment on the table
This is such an unmet need, and a real issue close to many people (my family included). Will be watching this closely, and hope this can be rolled out in New Zealand sometime soon.
ARCH incubated Rippl launches to tackle cognitive care for the elderly. For 20 years, I have wanted to back Kris Engskov! ARCH’s Inca Dieterich co-founded. General Catalyst co-led, with GV, F-prime, and Mass General Brigham Ventures investing. https://t.co/85DrG5ed7Y
Let's go! New Zealand needs to invest in this opportunity - we have the intellectual capital, we need the infrastructure. @drayeshaverrall - is this on the radar?
Yes! 🎉🎉 We love a government investing in technology that means a more sustainable future built with biology! Maybe our own government here in New Zealand government can follow suit? 👀https://t.co/lsh8wkYjGw
Some great people have been pushing this bioeconomy policy boulder uphill for over a decade. Some great news out today from the Biden White House with a new bioeconomy executive order. https://t.co/wpAu6qKvQQ
This article (https://t.co/r37OFDNYhB) + cup of coffee really made my morning! A highly recommended read if you're interested in biomaterials, Fantastic article @tsungxu. Super excited about what the future holds here and @humblebeebio will be part of this
New performance materials are coming.
Many are biomanufactured and some are scaling very fast. Their superior properties have enormous potential to improve a vast range of products.
https://t.co/suAJ8GFyLq
📣We have two exciting new fixed-term positions open.
1. Bring your big-picture thinking, fresh ideas and business-savvy to help guide our R&D by scoping out different market applications and/or revenue off ramps for our proof of concept biomaterial.
https://t.co/6MOfug0q5k
@michael_gilman@damiangarde I saw Stelios Papadopoulos at an event at the tail end my PhD in London. He was/is one of the my major inspirations for working in biotech. Great article @damiangarde
New article!
The last golden age of new materials was so long ago, we rarely think about materials as a driver of technological progress. I make the case that this is changing.
https://t.co/c1i0xZMl1I